Join

Ashok Leyland Pumps ₹200 Crore into Finance Arm, Hinduja Leyland to Fuel Growth

Publish Date : 28 Mar 2025

Ashok Leyland Ltd. has announced a ₹200 crore equity infusion into its subsidiary, Hinduja Leyland Finance Ltd. (HLF).

Key Points:

Purpose of Infusion: The capital will support HLF's growth initiatives and strengthen its financial position.
Method of Infusion: HLF will issue equity shares to Ashok Leyland in exchange for the ₹200 crore investment.
Strategic Importance: This move underscores Ashok Leyland's commitment to bolstering its financial services arm, enabling HLF to expand its lending portfolio and enhance market presence.

This strategic investment is expected to provide HLF with the necessary capital to pursue growth opportunities and reinforce its position in the financial services sector.

Source: https://www.ndtvprofit.com/markets/ashok-leyland-to-infuse-rs-200-crore-in-finance-arm

Comments

Trade Unlisted (TU) is not a stock exchange or an online platform for buying or selling unlisted shares, luxury assets, or real estate. It is not regulated by SEBI, IRDAI, RERA, or any other authority. Our focus is to provide information on unlisted startup companies, luxury assets, and real estate. We do not offer investment advice, guarantees, or warranties regarding any asset class. Investing in unlisted equities or alternative assets is high-risk and suitable only for accredited high-net-worth individuals (HNIs) with a long-term investment horizon. There is a possibility of capital loss, and investors should conduct their own due diligence and consult financial advisors before making decisions.The information on this website is for general informational purposes only and should not be construed as personalized investment advice or a recommendation to buy or sell any asset class. Market trends and data interpretations are illustrative and may not reflect actual future performance. TU is neither a stock exchange nor intends to be recognized as one under the Securities Contracts (Regulation) Act, 1956. We are not authorized to solicit investments, and the securities or asset classes discussed are not traded on regulated exchanges. While we strive for accuracy and timeliness, we make no representations or warranties regarding the completeness or reliability of the information. Any reliance on such information is at the user's own risk, and TU does not accept liability for decisions made based on this website.